Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement

被引:8
作者
De Marzo, Vincenzo [1 ,2 ]
Crimi, Gabriele [1 ]
Vercellino, Matteo [1 ]
Benenati, Stefano [1 ,2 ]
Pescetelli, Fabio [1 ,2 ]
Della Bona, Roberta [1 ]
Sarocchi, Matteo [1 ,2 ]
Canepa, Marco [1 ,2 ]
Balbi, Manrico [1 ,2 ]
Porto, Italo [1 ,2 ]
机构
[1] San Martino Hosp, DICATOV Cardiothorac & Vasc Dept, IRCCS Oncol & Neurosci, Genoa, Italy
[2] Univ Genoa, Dept Internal Med & Specialties DIMI, Clin Cardiovasc Dis, Viale Benedetto 15,10, I-16132 Genoa, Italy
关键词
Transcatheter aortic valve replacement; Heart valve prosthesis; Troponin; Heart injuries; Creatine kinase MB form; Troponin I; PROGNOSTIC VALUE; IMPLANTATION; INFARCTION; TROPONIN; DEFINITIONS; PREDICTORS; OUTCOMES;
D O I
10.1007/s00380-021-01861-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peri-procedural myocardial injury (PPMI) is a common complication after transcatheter valve replacement (TAVR), often remaining clinically silent. The role of valve type on PPMI and the association between PPMI and mortality are still unclear. We sought to evaluate predictors and outcome of PPMI after TAVR, and the impact of self-expandable valve (SEV) vs. balloon-expandable valve (BEV) deployment on PPMI. Consecutive patients who underwent successful TAVR in a single-center from January 2014 to December 2019 were included. PPMI was defined according to a modified Valve Academic Research Consortium (VARC)-2 definition as a post-procedure elevation of troponin (with a peak value >= 15-times the upper-reference limit) < 72 h after TAVR. We included 596 patients, of whom 258 (43.3%) were men. Mean age was 83.4 +/- 5.5 years. We deployed 368 (61.7%) BEV and 228 (38.3%) SEV. PPMI was observed in 471 (79.0%) patients. At multivariable analysis, SEV (OR 2.70, 95% CI 1.64-4.55, p < 0.001), creatinine clearance (OR 0.98, 95% CI 0.97-1.00, p = 0.011), and baseline ejection fraction (OR 1.05, 95% CI 1.02-1.07, p < 0.001) were independent predictors of PPMI; these findings were also confirmed using a propensity-weighted analysis. Thirty-day and 1-year all-cause mortality rates were 2.5% and 8.1%, respectively. No associations between PPMI and 30-day (p = 0.488) or 1-year (p = 0.139) all-cause mortality were found. Independent predictors of 30-day mortality were increasing EUROSCORE II (HR 1.16 per score point, 95% CI 1.08-1.19, p < 0.001) and life-threatening/major bleeding complications (HR 5.87, 95% CI 1.28-26.58, p = 0.019), whereas EUROSCORE II (HR 1.08, 95% CI 1.04-1.13, p = 0.031) and acute kidney injury (HR 2.59, 95% CI 1.20-5.35, p = 0.020) were related to 1-year mortality. PPMI is frequent after TAVR, but it does not affect 30-day or 1-year all-cause mortality. SEV implantation is associated with an increased frequency of PPMI.
引用
收藏
页码:1746 / 1755
页数:10
相关论文
共 31 条
[1]   Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care [J].
Apple, Fred S. ;
Sandoval, Yader ;
Jaffe, Allan S. ;
Ordonez-Llanos, Jordi .
CLINICAL CHEMISTRY, 2017, 63 (01) :73-81
[2]   Prevalence and Effect of Myocardial Injury After Transcatheter Aortic Valve Replacement [J].
Barbash, Israel M. ;
Dvir, Danny ;
Ben-Dor, Itsik ;
Badr, Salem ;
Okubagzi, Petros ;
Torguson, Rebecca ;
Corso, Paul J. ;
Xue, Zhenyi ;
Satler, Lowell F. ;
Pichard, Augusto D. ;
Waksman, Ron .
AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (09) :1337-1343
[3]   Clinical Outcomes After Transcatheter Aortic Valve Replacement Using Valve Academic Research Consortium Definitions A Weighted Meta-Analysis of 3,519 Patients From 16 Studies [J].
Genereux, Philippe ;
Head, Stuart J. ;
Van Mieghem, Nicolas M. ;
Kodali, Susheel ;
Kirtane, Ajay J. ;
Xu, Ke ;
Smith, Craig ;
Serruys, Patrick W. ;
Kappetein, A. Pieter ;
Leon, Martin B. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (25) :2317-2326
[4]   Myocardial injury during transfemoral transcatheter aortic valve implantation: an intracoronary Doppler and cardiac magnetic resonance imaging study [J].
Kahlert, Philipp ;
Al-Rashid, Fadi ;
Plicht, Bjoern ;
Wild, Carolin ;
Westhoelter, Dirk ;
Hildebrandt, Heike ;
Baars, Theodor ;
Neumann, Till ;
Nensa, Felix ;
Nassenstein, Kai ;
Wendt, Daniel ;
Thielmann, Matthias ;
Jakob, Heinz ;
Kottenberg, Eva ;
Peters, Juergen ;
Erbel, Raimund ;
Heusch, Gerd .
EUROINTERVENTION, 2016, 11 (12) :1401-1408
[5]   Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document [J].
Kappetein, A. Pieter ;
Head, Stuart J. ;
Genereux, Philippe ;
Piazza, Nicolo ;
van Mieghem, Nicolas M. ;
Blackstone, Eugene H. ;
Brott, Thomas G. ;
Cohen, David J. ;
Cutlip, Donald E. ;
van Es, Gerrit-Anne ;
Hahn, Rebecca T. ;
Kirtane, Ajay J. ;
Krucoff, Mitchell W. ;
Kodali, Susheel ;
Mack, Michael J. ;
Mehran, Roxana ;
Rodes-Cabau, Josep ;
Vranckx, Pascal ;
Webb, John G. ;
Windecker, Stephan ;
Serruys, Patrick W. ;
Leon, Martin B. .
EUROPEAN HEART JOURNAL, 2012, 33 (19) :2403-+
[6]   Myocardial injury associated with transcatheter aortic valve implantation (TAVI) [J].
Kim, Won-Keun ;
Liebetrau, Christoph ;
van Linden, Arnaud ;
Blumenstein, Johannes ;
Gaede, Luise ;
Hamm, Christian W. ;
Walther, Thomas ;
Moellmann, Helge .
CLINICAL RESEARCH IN CARDIOLOGY, 2016, 105 (05) :379-387
[7]   Detection of Myocardial Injury by CMR After Transcatheter Aortic Valve Replacement [J].
Kim, Won-Keun ;
Rolf, Andreas ;
Liebetrau, Christoph ;
Van Linden, Arnaud ;
Blumenstein, Johannes ;
Kempfert, Joerg ;
Bachmann, Georg ;
Nef, Holger ;
Hamm, Christian ;
Walther, Thomas ;
Moellmann, Helge .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (04) :349-357
[8]   Post-Procedural Troponin Elevation and Clinical Outcomes Following Transcatheter Aortic Valve Implantation [J].
Koskinas, Konstantinos C. ;
Stortecky, Stefan ;
Franzone, Anna ;
O'Sullivan, Crochan J. ;
Praz, Fabien ;
Zuk, Katazyrna ;
Raber, Lorenz ;
Pilgrim, Thomas ;
Moschovitis, Aris ;
Fiedler, Georg M. ;
Juni, Peter ;
Heg, Dik ;
Wenaweser, Peter ;
Windecker, Stephan .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02)
[9]   Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients [J].
Leon, Martin B. ;
Smith, Craig R. ;
Mack, Michael J. ;
Makkar, Raj R. ;
Svensson, Lars G. ;
Kodali, Susheel K. ;
Thourani, Vinod H. ;
Tuzcu, E. Murat ;
Miller, D. Craig ;
Herrmann, Howard C. ;
Doshi, Darshan ;
Cohen, David J. ;
Pichard, Augusto D. ;
Kapadia, Samir ;
Dewey, Todd ;
Babaliaros, Vasilis ;
Szeto, Wilson Y. ;
Williams, Mathew R. ;
Kereiakes, Dean ;
Zajarias, Alan ;
Greason, Kevin L. ;
Whisenant, Brian K. ;
Hodson, Robert W. ;
Moses, Jeffrey W. ;
Trento, Alfredo ;
Brown, David L. ;
Fearon, William F. ;
Pibarot, Philippe ;
Hahn, Rebecca T. ;
Jaber, Wael A. ;
Anderson, William N. ;
Alu, Maria C. ;
Webb, John G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (17) :1609-1620
[10]   Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. [J].
Leon, Martin B. ;
Smith, Craig R. ;
Mack, Michael ;
Miller, D. Craig ;
Moses, Jeffrey W. ;
Svensson, Lars G. ;
Tuzcu, E. Murat ;
Webb, John G. ;
Fontana, Gregory P. ;
Makkar, Raj R. ;
Brown, David L. ;
Block, Peter C. ;
Guyton, Robert A. ;
Pichard, Augusto D. ;
Bavaria, Joseph E. ;
Herrmann, Howard C. ;
Douglas, Pamela S. ;
Petersen, John L. ;
Akin, Jodi J. ;
Anderson, William N. ;
Wang, Duolao ;
Pocock, Stuart .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (17) :1597-1607